Drugs / iclaprim
iclaprim
also known as
AR-100 · AR-100.001 · Iclaprim mesilate · ICLAPRIM MESYLATE · Iclaprim methanesulfonate · Iclaprime · Iclaprimmonomesilate · RO 48-2622
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00543608 | Nov 2007 → Apr 2009 | nosocomial infection | Arpida AG | Terminated | No outcome recorded Stop: Business |
| Phase 34 trials · 2 met primary | ||||||
| Phase 3 | NCT02600611 | Nov 2015 → Jan 2017 | — | Motif Bio | Completed | Met primary |
| Phase 3 | NCT02607618 | Nov 2015 → Aug 2017 | — | Motif Bio | Completed | Met primary |
| Phase 3 | NCT00303550 | Mar 2006 → ? | skin disease caused by bacterial infection | Arpida AG | Completed | No outcome recorded |
| Phase 3 | NCT00299520 | Jun 2005 → Jul 2006 | — | Arpida AG | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iclaprim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00303550 ↗ |
| Known as | AR-100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | AR-100.001 | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | Iclaprim mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | ICLAPRIM MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | Iclaprim methanesulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | Iclaprime | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | Iclaprimmonomesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Known as | RO 48-2622 | ChEMBL registry synonym — accepted as the source's own label CHEMBL134561 ↗ |
| Modality | Small molecule | “Iclaprim, a diaminopyrimidine antimicrobial, was compared with vancomycin for treatment of patients with acute bacterial skin and skin-structure infections (ABSSSIs) in two...” PMID 29783024 ↗ May 2018 |
| Route | Intravenous | “intravenous iclaprim or intravenous linezolid” NCT00299520 ↗ |